Search Results 1531-1540 of 18736 for Activation

1. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

   ... activated partial thromboplastin time (aPTT)\* below institutional ULN * aspartate aminotransferase (AST) ≤1.5 x ULN * alanine aminotransferase (ALT) ≤1.5 ...

2. Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 - Mayo Clinic

   Participants must have a documented pathogenic activating variant, or variant of uncertain significance, of the CASR gene associated with biochemical ...

3. Cardiovascular Medicine - Clinical trials

   The purpose of this study is to obtain electro-anatomic maps of human myocardium in sinus rhythm and ventricular arrhythmias to identify activation patterns ...

4. Forging ahead after years of hardship - Mayo Clinic News Network

   DISCOVERING THE ACTIVATION OF THE GENE WAS LIKE “PURE ADRENALINE,” DR. LASHO SAYS. “IT WAS VERY EXCITING — WE JUST EAT AND SLEEP FOR THIS KIND OF TARGETABLE ...

5. Mayo Clinic discovers high-intensity aerobic training can reverse aging processes in adults

   All training types improved lean body mass and insulin sensitivity, but only high-intensity and combined training improved aerobic capacity and mitochondrial ...

6. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... activated partial thromboplastin time (aPTT) < 1.5 X ULN; if value is higher due to hepatic involvement by CLL, patient is eligible; No active hemolytic ...

7. Melanoma Surgical Oncology in Jacksonville - Clinical trials

   We present here a CAR design that allows PD-1 to recognize PD-L1 on the tumor; however, the intracellular CAR design is one that results in T cell activation as ...

8. Mononucleosis: Can it recur? - Mayo Clinic News Network

   Rarely, reactivated EBV may cause illness in people who have weak immune systems, such as those who have AIDS. Mononucleosis rarely leads to a serious condition ...

9. A Phase 1 Study Of The Safety And Tolerability Of MT-125 In GBM Patients - Mayo Clinic

   Prothrombin time (PT)/ International normalized ratio (INR)/ Activated partial thromboplastin time (aPTT) ≤1.5 x ULN OR if participant is receiving ...

10. Predoctoral Training Program in Molecular Pharmacology and Experimental Therapeutics student roster - Mayo Clinic Research

    D. Research focus. Anti-TCR (T cell receptors) and anti-CD3 Fab homodimerization and the effects of ligand bivalency on T cell activation. View trainee's ...